Abstract
In an in vitro study, the chemosensitivity of EFC-2 human glioma cells to ACNU, BCNU, cisplatin, and bleomycin sulfate was evaluated by growth suppression and colony forming assays. The EFC-2 cell line was cloned from a human glioblastoma multiforme. Cisplatin was the most effective agent in this study. ACNU and BCNU had very similar dose-response curves, although this result was not statistically significant.
